11 – 20 of 133
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Exploring the microbial landscape uncovering the pathogens associated with community-acquired pneumonia in hospitalized patients
(
- Contribution to journal › Article
-
Mark
Management of influenza–updated Swedish guidelines for antiviral treatment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intensive care unit burden is associated with increased mortality in critically ill COVID-19 patients
(
- Contribution to journal › Article
-
Mark
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection
(
- Contribution to journal › Article
- 2022
-
Mark
Remissyttrande: Yttrande över God tvångsvård – trygghet, säkerhet och rättssäkerhet i psykiatrisk tvångsvård och rättspsykiatrisk vård (SOU 2022:40)
2022)(
- Other contribution › Consultation response
-
Mark
Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19 : Protocol for a Pilot Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Psykiatrisk tvångsvård vid självskadebeteende – kan en person ha ett oundgängligt behov av en vård som inte hjälper?
(
- Contribution to journal › Article
-
Mark
Low numbers of COVID-19 in Swedish pediatric oncology patients during the first pandemic year despite an open society
(
- Contribution to journal › Article
-
Mark
Circulating Hepatocyte Growth Factor Reflects Activation of Vascular Repair in Response to Stress
(
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article